Form 4: BioLife Solutions CFO Executes Tax Withholding Transaction

CFO Troy Wichterman disposed of 1,026 shares of BioLife Solutions common stock to satisfy tax obligations related to restricted stock units.

Summary

• Troy Wichterman, Chief Financial Officer of BioLife Solutions, Inc. (BLFS), reported the disposal of 1,026 shares of common stock.
• The transaction occurred on June 8, 2026, at a price of $26.10 per share.
• The disposal was executed to satisfy tax withholding obligations associated with the vesting of restricted stock units.
• Following this transaction, the reporting person maintains a beneficial ownership of 215,030 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transaction is purely administrative and mandated by tax requirements.

Positives

• The transaction is a routine administrative action related to tax obligations rather than a discretionary sale of equity.

Negatives

• Reduction in the direct share ownership of a key executive.

Risks

• None identified; this is a standard tax-related transaction.

Future Outlook

No forward-looking guidance or strategic outlook provided in this filing.

Industry Context

StockSavvy.ai notes that tax-related share withholding is a standard corporate governance practice for executives receiving equity-based compensation and does not typically signal a change in management sentiment regarding company performance.

Comparison to Industry Standards

• The transaction aligns with standard executive compensation practices observed across the biotechnology and life sciences sectors.

Stakeholder Impact

• Minimal impact on shareholders as the transaction is a routine tax settlement.

Key Dates

Keywords

BioLife Solutions, BLFS, Insider Transaction, Form 4, Tax Withholding, CFO